LINDSEY PAGE: Open Payments
NPI 1265726152 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,250 in 116 payments from 36 companies in 2025. Trend: 2023 $18 · 2024 $999 · 2025 $2,250
Food & beverage: $2,250
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 14 | $294 |
| Janssen Biotech, Inc. | 13 | $232 |
| Novartis Pharmaceuticals Corporation | 14 | $190 |
| Astellas Pharma US Inc | 10 | $170 |
| ABBVIE INC. | 6 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Incyte Corporation | 5 | $106 |
| Daiichi Sankyo Inc. | 4 | $96 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| PFIZER INC. | 4 | $83 |
Products named: KEYTRUDA, VENCLEXTA, Xtandi, KISQALI, ERLEADA, EPKINLY, Lenvima, ULTOMIRIS.
Industry payments across KY — which companies pay providers there.
